Indo Us Bio-Tech Limited

Equities

INDOUS6

INE250Z01010

Biotechnology & Medical Research

Market Closed - Bombay S.E. Other stock markets 06:01:00 2024-07-05 am EDT			5-day change	1st Jan Change
212.8 ^INR	+0.24%		+1.33%	-10.78%

May. 02	Indo Us Bio-Tech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
Feb. 14	Indo Us Bio-Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Indo Us Bio-Tech Limited Announces Board Appointments

November 14, 2019 at 11:45 am EST

Indo Us Bio-Tech Limited announced that the Board of Directors of the company has appointed Ms. Nidhi Ajudia as an Additional Director (Non Executive Independent) and appointment of Mr. Samarth Patel as an Additional Director (Non Executive Independent).

Latest news about Indo Us Bio-Tech Limited

Indo Us Bio-Tech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 02	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Indo US Signs MoU with Navsari Agricultural University for Seed Production, Hybrid Rice Marketing	23-09-03	MT
Indo US Bio Tech Bags Contract for Supply of Hybrid Vegetable Seeds to Chhattisgarh, India	23-08-24	MT
Indo US Bio Tech Limited Enters into Rate Contract with Chhattisgarh State Seed and Agriculture Development Corporation Limited	23-08-24	CI
Indo US Bio-Tech to Issue Bonus Shares	23-07-07	MT
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-03	CI
Indo Us Bio-Tech Limited Announces Change in Composition of Committees of the Board	23-03-09	CI
Indo Us Bio-Tech Limited announced that it has received INR 61.0103 million in funding from Improwised Technologies Pvt. Ltd	22-09-08	CI
US Bio-Tech Sells 98.5% Stake in Subsidiary Agripari E-Commerce	22-07-28	MT
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-09	CI
Indo Us Bio-Tech Limited announced that it expects to receive INR 27.0855 million in funding	22-03-20	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-14	CI
Indo Us Bio-Tech Limited Declares Dividend	21-10-19	CI
Indo Us Bio-Tech Limited Recommends Dividend	21-10-09	CI
Indo Us Bio-Tech Limited Announces Resignation of Samarth Patel, Non- Executive and Independent Director	21-08-05	CI
976,000 Equity Shares of Indo Us Bio-Tech Limited are subject to a Lock-Up Agreement Ending on 14-MAY-2021.	21-05-13	CI
Indo Us Bio-Tech Limited Announces Resignation of Nidhi Ajudia as Non- Executive and Independent Director	21-02-10	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2020	20-11-13	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-30	CI
Indo Us Bio-Tech Limited Announces Appointment of Dimpy Joshi as Company Secretary and Compliance Officer	20-01-24	CI
Indo Us Bio-Tech Limited Announces Board Appointments	19-11-14	CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-14	CI
Indo US Bio-Tech Limited Announces Board Resignations	19-11-14	CI
Indo Us Bio-Tech Limited Approves Resignation of Sangeeta Dilipkumar Narwani as Company Secretary and Compliance Officer	19-08-09	CI

Chart Indo Us Bio-Tech Limited

Duration

Period

More charts

Company Profile

Indo US Bio-Tech Limited is engaged in research and development throw breeding, production of seeds, processing, packing and marketing of hybrid and open pollinated varieties of agricultural crops. It is also engaged in educating the local farmers by demonstration of various cultivated research crops. Its product portfolio includes a diversified variety of agriculture seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, cumin, coriander and others. It has a distribution network in the state of Gujarat, Maharashtra, Madhya Pradesh, Chhattisgarh, Rajasthan, Himanchal Pradesh, Punjab, Bihar, Uttar Pradesh, Karnataka, Jharkhand and others. It also exports to many countries, namely the United States, New Jersey, Palestine, Maimi USA, Cameroon, Kuwait, Sri Lanka and Mauritius.

Sector

Biotechnology & Medical Research

Calendar

2024-08-11 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
INDO US BIO-TECH LIMITED	-10.78%	51.11M
MODERNA, INC.	+18.97%	45.34B
LONZA GROUP AG	+41.98%	40.42B
IQVIA HOLDINGS INC.	-10.06%	37.92B
ALNYLAM PHARMACEUTICALS, INC.	+31.15%	31.75B
CELLTRION, INC.	-7.79%	27.71B
ICON PUBLIC LIMITED COMPANY	+13.32%	26.52B
UNITED THERAPEUTICS CORPORATION	+43.05%	13.96B
MEDPACE HOLDINGS, INC.	+31.28%	12.44B
BIO-TECHNE CORPORATION	-7.41%	11.26B

Other Biotechnology & Medical Research